BCRX
#1927
BioCryst Pharmaceuticals, Inc. - Common Stock
8.0 7 USD
-0.03%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-3.47%
Changement Mensuel
-1.47%
Evolution sur 6 mois
-17.23%
Changement Annuel
+23.77%
Clôture Précédente
8.3 6
Open
8.2 2
Low
8.0 6
High
8.3 2
Financials
- Market Capitalization 2.06 B
- Employee 435
- Founded 1986
- CEO Jon P. Stonehouse
- Website www.biocryst.com
- Headquarter Delaware, United States
- FIGI BBG000BLYWX6
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
6.45
ratio cours/chiffre d'affaires
1.95
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1924 |  VRDN Viridian Therapeutics, Inc. - Common Stock | 18.22 USD | -0.44% | +1.11% | -17.11% | -18.84% | 2.06 B USD | ||
| 1925 |  VCEL Vericel Corporation - Common Stock | 40.30 USD | -0.79% | +1.59% | +2.31% | +10.87% | 2.06 B USD | ||
| 1931 |  RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.84 USD | -4.24% | -14.86% | +14.29% | -36.32% | 2.06 B USD | ||
| 1946 |  IMNM Immunome, Inc. - Common Stock | 17.58 USD | -8.20% | -7.18% | -28.07% | +25.66% | 2.00 B USD |